Moritz Moller
Overview
Explore the profile of Moritz Moller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
84
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Niederberger E, Moller M, Mungo E, Hass M, Wilken-Schmitz A, Manderscheid C, et al.
FASEB J
. 2023 Nov;
37(12):e23287.
PMID: 37930651
Epidemiological studies show a coincidence between Parkinson's disease (PD) and malignant melanoma. It has been suggested that this relationship is due, at least in part, to modulation of alpha-Synuclein (αSyn/Snca)....
2.
Moller M, Moser C, Weiss U, Niederberger E
Cells
. 2022 Jun;
11(12).
PMID: 35741096
(1) AlphαSynuclein (αSyn) is a synaptic protein which is expressed in the nervous system and has been linked to neurodegenerative diseases, in particular Parkinson's disease (PD). Symptoms of PD are...
3.
Moller M, Manohar S, Bogacz R
PLoS Comput Biol
. 2022 May;
18(5):e1009816.
PMID: 35622863
To accurately predict rewards associated with states or actions, the variability of observations has to be taken into account. In particular, when the observations are noisy, the individual rewards should...
4.
Weiss U, Moller M, Husseini S, Manderscheid C, Hausler J, Geisslinger G, et al.
Int J Mol Sci
. 2020 Dec;
21(23).
PMID: 33255670
Class I and II histone deacetylases (HDAC) are considered important regulators of immunity and inflammation. Modulation of HDAC expression and activity is associated with altered inflammatory responses but reports are...
5.
Moller M, Wasel J, Schmetzer J, Weiss U, Meissner M, Schiffmann S, et al.
Int J Mol Sci
. 2020 Jul;
21(13).
PMID: 32630674
Inhibitor-kappaB kinase epsilon (IKKε) and TANK-binding kinase 1 (TBK1) are non-canonical IκB kinases, both described as contributors to tumor growth and metastasis in different cancer types. Several hints indicate that...
6.
Albus A, Jordens M, Moller M, Dodel R
Front Immunol
. 2019 Sep;
10:2033.
PMID: 31507618
There is no effective disease-modifying therapy for Alzheimer's or Parkinson's disease. As pathological hallmarks, the specific peptide amyloid-β and the specific protein α-Synuclein aggregate and deposit in and destabilize neurons,...
7.
Martin L, Moller M, Weiss U, Russe O, Scholich K, Pierre S, et al.
Int J Mol Sci
. 2019 Jul;
20(13).
PMID: 31269729
The stimulation of the AMP-activated kinase (AMPK) by 5-amino-1-β-D-ribofuranosyl-imidazole-4-carboxamide (AICAR) has been associated with antihyperalgesia and the inhibition of nociceptive signaling in the spinal cord in models of paw inflammation....
8.
Moller M, Bogacz R
PLoS Comput Biol
. 2019 Mar;
15(2):e1006285.
PMID: 30818357
A set of sub-cortical nuclei called basal ganglia is critical for learning the values of actions. The basal ganglia include two pathways, which have been associated with approach and avoid...
9.
Moser C, Moller M, Fleck S, Thomas D, Geisslinger G, Niederberger E
Neuropharmacology
. 2018 Dec;
146:198-211.
PMID: 30528326
Inhibitor-kappaB kinase epsilon (IKKε, Ikbke) constitutes an NF-κB activating kinase with high homology to the classical I-κB kinase subunits, IKKα and IKKβ. It is expressed in nociceptive neurons in the...
10.
King-Himmelreich T, Moser C, Wolters M, Schmetzer J, Moller M, Schreiber Y, et al.
Mol Pain
. 2017 Apr;
13:1744806917703111.
PMID: 28381108
Background: Caloric restriction is associated with broad therapeutic potential in various diseases and an increase in health and life span. In this study, we assessed the impact of caloric restriction...